Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease
Authors:
- 18 July 2006
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 24 (2) , 361-370
Abstract
Low dopaminergic cell survival and suboptimal fiber reinnervation are likely major contributing factors for the limited benefits of neural transplantation in Parkinson's disease (PD) patients. Glial cell lined‐derived neurotrophic factor (GDNF) has been shown to enhance dopaminergic cell survival and fiber outgrowth of the graft site as well as promote behavioral recovery in rodent models of PD, while erythropoietin (EPO) can produce dopaminergic neuroprotective effects against 6‐hydroxydopamine (6‐OHDA) exposure on cultured neurons and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated mice. The aim of this study was to determine if fetal ventral mesencephalic (FVM) tissue exposed to hibernation media containing a combination of GDNF and EPO could enhance dopaminergic graft survival, striatal reinnervation and functional recovery in a 6‐OHDA rodent model of PD. FVM tissue was dissected from 14‐day‐old rat fetuses and placed for 6 days in hibernation media alone, and in hibernation media that received either a daily administration of GDNF, EPO or a combination of GDNF and EPO. Following hibernation, FVM cells were transplanted as a single cell suspension into the striatum of unilateral 6‐OHDA‐lesioned rats. Rotational behavioral assessment revealed animals that received FVM tissue exposed to GDNF, EPO or the combination of both drugs had accelerated functional recovery. Immunohistochemical and stereological assessment revealed a significant increase in graft fiber density and angiogenesis into the graft when compared with control. These findings suggest that the hibernation of FVM tissue in a combination of GDNF and EPO can enhance graft efficacy and may have important implications for tissue preparation protocols for clinical neural transplantation in PD.Keywords
This publication has 88 references indexed in Scilit:
- The role of erythropoietin in regulating angiogenesisDevelopmental Biology, 2004
- Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblastsNeuroscience Letters, 2004
- Signal Transduction in the Erythropoietin Receptor SystemExperimental Cell Research, 1999
- Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell LinesJournal of Biological Chemistry, 1999
- Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral ArteryBiochemical and Biophysical Research Communications, 1998
- Glial Cell Line-Derived Neurotrophic Factor Improves Survival of Dopaminergic Neurons in Transplants of Fetal Ventral Mesencephalic TissueExperimental Neurology, 1998
- GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral graftsNeuroReport, 1996
- GDNF reduces apoptosis in dopaminergic neurons in vitroNeuroReport, 1995
- Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's diseaseAnnals of Neurology, 1995
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993